INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $257,158,828 | -21.7% | 8,132,790 | +1.0% | 0.01% | -22.2% |
| Q2 2023 | $328,481,402 | +19.9% | 8,054,963 | +9.6% | 0.01% | +12.5% |
| Q1 2023 | $273,883,042 | +8.2% | 7,348,619 | +1.3% | 0.01% | 0.0% |
| Q4 2022 | $253,135,543 | -26.2% | 7,255,246 | +18.4% | 0.01% | -33.3% |
| Q3 2022 | $342,930,000 | +12.5% | 6,128,140 | +4.1% | 0.01% | +20.0% |
| Q2 2022 | $304,731,000 | -25.1% | 5,887,399 | +5.1% | 0.01% | -9.1% |
| Q1 2022 | $407,079,000 | -38.7% | 5,601,739 | -0.3% | 0.01% | -35.3% |
| Q4 2021 | $664,553,000 | -10.4% | 5,620,376 | +1.6% | 0.02% | -19.0% |
| Q3 2021 | $741,985,000 | -7.7% | 5,530,995 | +11.4% | 0.02% | -4.5% |
| Q2 2021 | $803,974,000 | +90.0% | 4,965,565 | -5.8% | 0.02% | +83.3% |
| Q1 2021 | $423,074,000 | +53.9% | 5,271,626 | +4.3% | 0.01% | +33.3% |
| Q4 2020 | $274,876,000 | +144.9% | 5,052,845 | -10.5% | 0.01% | +125.0% |
| Q3 2020 | $112,224,000 | +5.7% | 5,645,009 | +11.8% | 0.00% | 0.0% |
| Q2 2020 | $106,168,000 | +128.9% | 5,050,826 | +33.2% | 0.00% | +100.0% |
| Q1 2020 | $46,379,000 | -13.3% | 3,792,298 | +4.0% | 0.00% | 0.0% |
| Q4 2019 | $53,476,000 | +11.9% | 3,645,230 | +1.8% | 0.00% | 0.0% |
| Q3 2019 | $47,800,000 | -13.9% | 3,580,598 | +5.6% | 0.00% | 0.0% |
| Q2 2019 | $55,499,000 | +2.1% | 3,390,267 | +6.6% | 0.00% | 0.0% |
| Q1 2019 | $54,343,000 | +38.8% | 3,181,719 | +10.9% | 0.00% | 0.0% |
| Q4 2018 | $39,158,000 | -50.1% | 2,868,738 | +4.5% | 0.00% | -33.3% |
| Q3 2018 | $78,545,000 | +12.3% | 2,744,397 | +7.4% | 0.00% | 0.0% |
| Q2 2018 | $69,940,000 | +92.5% | 2,556,299 | +48.4% | 0.00% | +50.0% |
| Q1 2018 | $36,338,000 | +10.5% | 1,722,962 | +0.7% | 0.00% | 0.0% |
| Q4 2017 | $32,885,000 | -21.2% | 1,710,947 | +1.9% | 0.00% | 0.0% |
| Q3 2017 | $41,730,000 | +55.7% | 1,679,285 | +0.2% | 0.00% | +100.0% |
| Q2 2017 | $26,806,000 | +101.7% | 1,675,336 | +77.6% | 0.00% | 0.0% |
| Q1 2017 | $13,293,000 | +265760.0% | 943,344 | +235147.9% | 0.00% | – |
| Q4 2016 | $5,000 | -28.6% | 401 | 0.0% | 0.00% | – |
| Q3 2016 | $7,000 | -86.8% | 401 | -83.7% | 0.00% | – |
| Q2 2016 | $53,000 | – | 2,464 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |